Cegla, P.; Currie, G.; Wróblewska, J.P.; Cholewiński, W.; Kaźmierska, J.; Marszałek, A.; Kubiak, A.; Golusinski, P.; Golusiński, W.; Majchrzak, E.
Influence of Semiquantitative [18F]FDG PET and Hematological Parameters on Survival in HNSCC Patients Using Neural Network Analysis. Pharmaceuticals 2022, 15, 224.
https://doi.org/10.3390/ph15020224
AMA Style
Cegla P, Currie G, Wróblewska JP, Cholewiński W, Kaźmierska J, Marszałek A, Kubiak A, Golusinski P, Golusiński W, Majchrzak E.
Influence of Semiquantitative [18F]FDG PET and Hematological Parameters on Survival in HNSCC Patients Using Neural Network Analysis. Pharmaceuticals. 2022; 15(2):224.
https://doi.org/10.3390/ph15020224
Chicago/Turabian Style
Cegla, Paulina, Geoffrey Currie, Joanna P. Wróblewska, Witold Cholewiński, Joanna Kaźmierska, Andrzej Marszałek, Anna Kubiak, Pawel Golusinski, Wojciech Golusiński, and Ewa Majchrzak.
2022. "Influence of Semiquantitative [18F]FDG PET and Hematological Parameters on Survival in HNSCC Patients Using Neural Network Analysis" Pharmaceuticals 15, no. 2: 224.
https://doi.org/10.3390/ph15020224
APA Style
Cegla, P., Currie, G., Wróblewska, J. P., Cholewiński, W., Kaźmierska, J., Marszałek, A., Kubiak, A., Golusinski, P., Golusiński, W., & Majchrzak, E.
(2022). Influence of Semiquantitative [18F]FDG PET and Hematological Parameters on Survival in HNSCC Patients Using Neural Network Analysis. Pharmaceuticals, 15(2), 224.
https://doi.org/10.3390/ph15020224